Long‐Term Disease‐Free Survival After Systemic‐First Sequential Multimodal Therapy for Advanced and Recurrent Large‐Cell Neuroendocrine Carcinoma of the Uterine Cervix: A Case Report
Journal of Obstetrics and Gynaecology Research · 2026
DOI: 10.1111/jog.70341 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2026. Verfasst von Kimio Wakana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Carcinoma, Neuroendocrine, Neoplasm Recurrence, Local, Carcinoma, Large Cell. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cervical large‐cell neuroendocrine carcinoma (LCNEC) is a rare and highly aggressive malignancy with poor prognoses, particularly in advanced or recurrent disease. We describe a case of advanced and recurrent cervical LCNEC in which long‐term disease‐free survival was achieved following a systemic‐first, sequential multimodal treatment strategy. A 41‐year‐old woman presented with abnormal vaginal bleeding and was diagnosed with cervical LCNEC with pelvic and para‐aortic lymph node metastases. Neoadjuvant irinotecan–cisplatin chemotherapy resulted in marked tumor regression, enabling radical hysterectomy. Postoperative therapy consisted of etoposide–cisplatin chemotherapy, followed by pelvic and para‐aortic radiotherapy. Mediastinal lymph node recurrence developed 3 years later and was successfully treated using the same chemotherapy regimen combined with site‐directed radiotherapy, resulting in complete remission. The patient remained disease‐free 9 years after the final treatment completion. This case suggests that carefully sequenced systemic chemotherapy, surgery, and radiotherapy integration may provide durable disease control in selected patients with advanced or recurrent cervical LCNEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Institute of Science Tokyo, Tokyo, Japan.
- Department of Perinatal and Maternal Medicine (Ibaraki), Institute of Science Tokyo, Tokyo, Japan.
- Department of Women's Health, Institute of Science Tokyo, Tokyo, Japan.
ORCID-Profile: Kimio Wakana
Zitieren
APA
Wakana, K., Akita, M., Tsubata, F., Kori, Y., Odai, T., & Miyasaka, N. (2026). Long‐Term Disease‐Free Survival After Systemic‐First Sequential Multimodal Therapy for Advanced and Recurrent Large‐Cell Neuroendocrine Carcinoma of the Uterine Cervix: A Case Report. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70341
Vancouver
Wakana K, Akita M, Tsubata F, Kori Y, Odai T, Miyasaka N. Long‐Term Disease‐Free Survival After Systemic‐First Sequential Multimodal Therapy for Advanced and Recurrent Large‐Cell Neuroendocrine Carcinoma of the Uterine Cervix: A Case Report. Journal of Obstetrics and Gynaecology Research. 2026. doi:10.1111/jog.70341
BibTeX
@article{Wakana2026,
author = {Wakana, Kimio and Akita, Mayu and Tsubata, Fumiko and Kori, Yusuke and Odai, Tamami and Miyasaka, Naoyuki},
title = {Long‐Term Disease‐Free Survival After Systemic‐First Sequential Multimodal Therapy for Advanced and Recurrent Large‐Cell Neuroendocrine Carcinoma of the Uterine Cervix: A Case Report},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
doi = {10.1111/jog.70341}
}
EUVIMED